AbbVie's drug portfolio and pipeline are both exceptional. Air Products & Chemicals is a wonderful business in a pivotal industry.
The NY Fed estimates a 68% recession probability within the next 12 months, the highest risk in 42 years. Dividend aristocrats can provide a relatively safe investment option during a recession, with

7 Best Dividend Stocks to Buy Now in June 2023

04:23pm, Thursday, 01'st Jun 2023
These top dividend stocks are attractive at these levels and lower, and they add excellent diversity to a long-term investing portfolio.

Why AbbVie and Amgen Are Moving Lower Today

12:50pm, Thursday, 01'st Jun 2023
Today, Coherus and Mark Cuban announced a partnership to launch an ultra-low-priced Humira biosimilar. This steep discount might have negative consequences for both AbbVie and Amgen later on this year

Buy 7 June Dividend Kings And Watch 3

04:34pm, Wednesday, 31'st May 2023
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
This article discusses three high-yielding stocks for retirees and income-oriented investors: ONEOK, AbbVie, and Realty Income. ONEOK is a cyclical income play with a 6.5% yield, AbbVie offers a high-

Should You Pick AbbVie Stock Over LLY?

07:00am, Friday, 26'th May 2023
Looking at stock returns, Eli Lilly has outperformed AbbVie and the broader indices.

Best Retirement Stocks to Buy Now

01:26pm, Thursday, 25'th May 2023
The best retirement stocks ideally have high dividend yields that can be sustained. This can lead to steady income and long-term value for retirees.
AbbVie's Humira now faces competition from biosimilars, but things look more promising in the long run. 3M's margins have been shrinking, but its biggest risk is the plethora of lawsuits relating to i
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Markets are racing higher as the earnings season turned out much better than expected. Sector rotation into tech stocks has led to a surge in big-tech with Nvidia clearly leading the pack.
The FDA approves AbbVie's (ABBV) epcoritamab, to be marketed as Epkinly, for relapsed/refractory large B-cell lymphoma, a form of NHL. Epkinly is AbbVie's third blood cancer drug.
AbbVie stock is down 10% after Q1 earnings. The mixed-bag quarter offered clarity on the effect of Humira's lost sales, Rinvoq and Skyrizi, and other franchises.
AbbVie's current headwinds are only temporary. Gilead Sciences' business remains rock-solid.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE